首页> 外国专利> Imidazopirazinonas PDE1 inhibitors

Imidazopirazinonas PDE1 inhibitors

机译:咪唑并吡嗪并鼻酮PDE1抑制剂

摘要

Refers to a compound of formula I wherein n is 0 OR 1, Q is 0 OR 1; r1 is selected from the group consisting of benzyl, indanilo,Heteroarilos indoline and 5 members; all of which can be substituted with a Halogen Substituent selected from the group consisting of C1 and C3 alkyl -,Among others; R2 is selected from the group consisting of hydrogen, C1 to C8 - linear or branched alkyl, phenyl, among others; R3 is selected from the group consisting of hydrogen, halogen,C1 - C5 alkyl; R4 is Hydrogen.These compounds are inhibitors of phosphodiesterase 1 (PDE1 Enzymes), regulating the intracellular Signalling Pathways, preferably in the nervous system.Or enhance the levels of the second Messengers Camp / cGMP. It also relates to pharmaceutical composition.These compounds are useful in the treatment of neurodegenerative Disorders and Psychiatric Disorders.
机译:指式I的化合物,其中n为0或1,Q为0或1; r1选自苄基,茚满基,杂芳二氢吲哚和5个成员;所有这些都可以被选自C 1和C 3烷基的卤素取代基所取代; R 2选自氢,C 1至C 8-直链或支链烷基,苯基等。 R3选自氢,卤素,C1-C5烷基; R4是氢,这些化合物是磷酸二酯酶1(PDE1酶)的抑制剂,可调节细胞内信号传导途径,优选在神经系统中起作用,或增强第二个Messengers Camp cGMP的水平。它还涉及药物组合物。这些化合物可用于治疗神经退行性疾病和精神疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号